Predictors of hospitalization for injection drug users seeking care for soft tissue infections

Journal of General Internal Medicine

Volumn 22, Issue 3, 2007, Pages 382-388

  Takahashi, Traci A ^a,c   Baernstein, Amy ^b,c   Binswanger, Ingrid ^d   Bradley, Katharine ^a,c   Merrill, Joseph O ^b,c  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Abscess; Cellulitis; Injection drug use; Soft tissue infection; Substance abuse

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; EMERGENCY WARD; FEMALE; HEALTH BEHAVIOR; HEALTH CARE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SOCIAL PSYCHOLOGY; SOFT TISSUE INFECTION; STRUCTURED INTERVIEW; THERAPY DELAY; COMPARATIVE STUDY; HEALTH SERVICE; INTERVIEW; LENGTH OF STAY; METHODOLOGY; MIDDLE AGED; PATIENT ATTITUDE; PREDICTION AND FORECASTING; SUBSTANCE ABUSE;

ADULT; COHORT STUDIES; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HOSPITALIZATION; HUMANS; INTERVIEWS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; SOFT TISSUE INFECTIONS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34250373761     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-006-0079-y     Document Type: Article

References (20)

1. Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30(3):579-81.
2. CDC. Unexplained illness and death among injecting-drug users-Glasgow, Scotland; Dublin, Ireland; and England, April-June 2000. MMWR. 2000;49(22):489-92.
3. Lonergan S, Rodriguez RM, Schaulis M, Navaran P. A case series of patients with black tar heroin-associated necrotizing fasciitis. J Emerg Med. 2004;26(1):47-50.
4. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco [see comment]. Clin Infect Dis. 2002;34(4):425-33.
5. Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in Emergency Department skin and soft tissue infections. Ann Emerg Med. 2005;45(3):311-20.
6. Young DM, Harris HW, Charlebois ED, et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004;139(9):947-51; discussion 951-3.
7. Morgan G, Krishnadasan A, Gorwitz R, et al. Methicillin-resistant S. aureus infections among patients in the Emergency Department. N Engl J Med. 2006;355(7):666-74.
8. CDC. Soft tissue infections among injection drug users-San Francisco, California, 1996-2000. MMWR. 2001;50(19):381-4.
9. Wallace JR, Lucas CE, Ledgerwood AM. Social, economic, and surgical anatomy of a drug-related abscess. Am Surgeon. 1986;52(7):398-401.
10. Palepu A, Tyndall MW, Leon H, et al. Hospital utilization and costs in a cohort of injection drug users. CMAJ. 2001;165(4):415-20.
11. Takahashi TA, Merrill JO, Boyko EJ, Bradley KA. Type and location of injection drug use-related soft tissue infections predict hospitalization. J Urban Health. 2003;80(1):127-36.
12. Sacks JA, Drake RE, Williams VF, Banks SM, Herrell JM. Utility of the time-line follow-back to assess substance use among homeless adults. J Nerv Ment Dis. 2003;191(3):145-53.
13. Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000;19(3):247-52.
14. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397-401.
15. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA, for the Ambulatory Care Quality Improvement Project. The AUDIT Alcohol Consumption Questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158(16):1789-95.
16. Dawson DA, Grant BF, Stinson FS, Zhou Y. Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcohol Clin Exp Res. 2005;29(5):844-54.
17. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992;9(3):199-213.
18. Murphy EL, DeVita D, Liu H, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33(1):35-40.
19. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2005;41(S4):S269-72.
20. Baillargeon J, Kelley MF, Leach CT, Baillargeon G, Pollock BH. Methicillin-resistant Staphylococcus aureus infection in the Texas prison system. Clin Infect Dis. 2004;38(9):e92-5.